Paracetamol + Methocarbamol Apap (Methocarbamol, Paracetamol)

Paracetamol reduces pain by inhibiting central cyclo‑oxygenase enzymes, lowering prostaglandin production. Methocarbamol acts on the central nervous system to depress neuronal activity in the spinal cord, decreasing muscle tone and spasm. Together they address both pain and the muscular component of many disorders.

The specific dose and dosing schedule are determined by the prescribing healthcare professional based on the patient’s age, weight, clinical condition, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety in pregnancy and lactation should be evaluated by a qualified healthcare provider. Paracetamol is generally considered low risk when used at recommended doses, but methocarbamol lacks extensive pregnancy data. Consultation with a physician is essential before use.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with single‑ingredient analgesics, the combination offers both pain relief and muscle relaxation in a single tablet, potentially reducing the need for additional muscle‑relaxant prescriptions. It may be preferred when pain is accompanied by spasm, whereas pure NSAIDs or opioids lack the muscle‑relaxant component.

Store the tablets at ambient temperature, preferably below 25 °C. Keep them in the original container, protect from moisture, heat, and direct sunlight. Ensure the packaging remains sealed until use to maintain product integrity.

The medication is taken orally, usually with a full glass of water. It can be taken with or without food, but patients who experience gastrointestinal discomfort may prefer taking it with meals. Follow the prescriber’s dosing instructions precisely.

Serious risks include hepatotoxicity from excessive paracetamol exposure, severe skin reactions such as Stevens‑Johnson syndrome, and rare blood disorders. Patients should seek immediate medical attention if they notice rash, jaundice, unexplained bruising, or signs of an allergic reaction.

Individuals with known hypersensitivity to either paracetamol or methocarbamol, severe liver disease, or those taking other medications containing paracetamol should avoid this product. Pregnant or breastfeeding women, as well as patients with significant renal impairment, should only use it after medical evaluation.